Back HIV Populations

HIV Populations

New HIV Infections Decline by 60% Among Children in Most Affected African Countries

HIV incidence has fallen dramatically for children in the African countries with the highest burdens of the disease, more pregnant women are receiving prophylactic antiretrovirals to prevent transmission, and half of infected children are now on antiretroviral treatment, according to a new UNAIDS report release this month to coincide with the United Nations General Assembly High-Level Meeting on Ending AIDS.

alt

Read more:

FDA Approves Dolutegravir for Smaller Children with HIV

The U.S. Food and Drug Administration this week approved a supplemental indication for the HIV integrase inhibitor dolutegravir (Tivicay), allowing its use for children age 6 years and older who weigh as little as 30 kg. The drug is currently being evaluated in younger and smaller children.

alt

Read more:

Positively Trans Survey Looks at Lives of Transgender People Living with HIV

The Transgender Law Center (TLC) released in March the first report of findings from its Positively Trans survey, which aims to learn more about the lives and experiences of transgender people living with HIV.TLC, working with a national advisory board of trans community leaders and with support from the Elton John AIDS Foundation, launched the survey in response to the structural inequities that drive the high rate of HIV/AIDS and poor health outcomes among trans people.

alt

Read more:

High Prevalence of Geriatric Conditions Among HIV+ People Over Age 50 in San Francisco

Older HIV-positive people have a high prevalence of multiple age-related problems, investigators reported in the March 29 online edition of the Journal of Acquired Immune Deficiency Syndromes. The research involved people aged 50 years and older receiving outpatient care in San Francisco. Overall, 40% reported difficulties with daily activities, most reported loneliness, many had mild cognitive impairment, and 30% had only poor to fair quality of life.

alt

Read more:

California Demonstration Projects to Study HIV PrEP for Transgender People

The California HIV/AIDS Research Program has announced funding for 3 new pre-exposure prophylaxis (PrEP) demonstration projects that will explore the use of Truvada (tenofovir/emtricitabine) for HIV prevention for transgender women and men, with a focus on improving adherence and monitoring interactions between antiretrovirals and gender-affirming hormone therapy.

alt

Read more: